The modulation of the alternative pathway of complement in C2-deficient human serum by changes in concentration of the component and control proteins.
D000818:Animals; D003175:Complement C2 / Q000172:deficiency*; D003176:Complement C3; D003180:Complement C3b Inactivator Proteins; D011415:Complement Factor B; D003165:Complement System Proteins; D004912:Erythrocytes / Q000276:immunology; D006461:Hemolysis; D006801:Humans; D011817:Rabbits; D015054:Zymosan / Q000494:pharmacology
D003175:Complement C2; D003176:Complement C3; D003180:Complement C3b Inactivator Proteins; D003165:Complement System Proteins; D015054:Zymosan; D011415:Complement Factor B